Moreover, to verify whether ITGB3BP expression is an independent factor affecting the survival of glioma patients, we conducted univariate and multivariate analyses based on different datasets, and the results showed that ITGB3BP up‐regulation could be an independent risk factor for the prognosis of glioma (Figure 4A–F). This evidence concerns the gene ITGB3BP and central nervous system cancer.